ST. PAUL, Minn.--(BUSINESS WIRE)--Synovis Life Technologies, Inc. (Nasdaq: SYNO), through a wholly-owned subsidiary, has completed its purchase of substantially all the assets of Pegasus Biologics, Inc., a privately held medical device company focused on the development of advanced biological solutions for soft tissue repair. As announced on July 7, the purchase price was $12.1 million in cash. Synovis will retain manufacturing operations in Irvine, Calif., and operate the acquired assets as a separate division.
